Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NTLA | AZN | AMGN | GILD | VRTX |
| Company | Intellia Thera CS | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 7.36 | 67.80 | 277.29 | 104.10 | 488.00 |
| High | 8.33 | 67.91 | 278.25 | 105.22 | 490.83 |
| Low | 7.15 | 66.59 | 270.36 | 103.09 | 472.90 |
| Last | 7.92 | 66.90 | 273.68 | 104.33 | 477.52 |
| Change | +0.69 | -0.69 | -3.61 | -0.21 | -11.58 |
| % Change | +9.54% | -1.02% | -1.30% | -0.20% | -2.37% |
| Volume | 5,618,100 | 2,573,000 | 1,803,500 | 6,720,900 | 1,176,400 |
| 20-Day Average Volume | 3,896,415 | 6,708,035 | 3,242,495 | 9,378,360 | 1,688,760 |
| Previous Close | 7.23 | 67.59 | 277.29 | 104.54 | 489.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.42 | 69.66 | 295.97 | 107.33 | 488.29 |
| 20-Day Raw Stochastic | 58.05% | 39.14% | 12.51% | 40.22% | 44.63% |
| 20-Day Relative Strength | 47.32% | 40.26% | 37.66% | 45.58% | 46.88% |
| Weighted Alpha | -65.28 | -13.84 | -5.73 | +54.93 | +15.26 |
| Today's Opinion | 88% Sell | 72% Sell | 56% Sell | 40% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 56% Sell | 40% Buy | 64% Buy |
| Last Month's Opinion | 100% Sell | 56% Buy | 56% Buy | 80% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.88% since 04/11/25 | +0.92% since 04/11/25 | -4.30% since 04/11/25 | +0.68% since 04/11/25 | -1.38% since 04/11/25 |
| Low | 6.73 on 04/16/25 | 66.59 on 04/21/25 | 268.50 on 04/17/25 | 103.09 on 04/21/25 | 472.90 on 04/21/25 |
| High | 8.33 on 04/21/25 | 68.40 on 04/15/25 | 296.17 on 04/15/25 | 107.18 on 04/14/25 | 502.22 on 04/16/25 |
| 1-Month | |||||
| %Chg | -12.00% since 03/21/25 | -10.72% since 03/21/25 | -13.40% since 03/21/25 | -2.57% since 03/21/25 | -5.10% since 03/21/25 |
| Low | 5.90 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 97.32 on 04/09/25 | 448.14 on 04/07/25 |
| High | 9.38 on 03/24/25 | 75.70 on 04/03/25 | 317.58 on 03/24/25 | 114.75 on 04/03/25 | 513.97 on 03/24/25 |
| 3-Month | |||||
| %Chg | -20.32% since 01/21/25 | -1.56% since 01/21/25 | -0.41% since 01/21/25 | +12.23% since 01/21/25 | +11.60% since 01/21/25 |
| Low | 5.90 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 91.84 on 01/22/25 | 424.54 on 01/23/25 |
| High | 12.84 on 02/20/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -61.68% since 10/21/24 | -13.61% since 10/21/24 | -13.59% since 10/21/24 | +20.91% since 10/21/24 | -0.12% since 10/21/24 |
| Low | 5.90 on 04/07/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 85.60 on 10/22/24 | 377.85 on 12/19/24 |
| High | 21.17 on 10/23/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 748,428 | 209,611,056 | 149,085,248 | 130,169,344 | 125,595,992 |
| Shares Outstanding, K | 103,517 | 3,101,214 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 57,880,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -519,020,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 12,870,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -128,900,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 2.23 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.24 on 02/27/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/08/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.31 | 14.26 | 22.75 | 0.00 |